• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].

作者信息

Takahashi K

出版信息

Nihon Ketsueki Gakkai Zasshi. 1980 Oct;43(5):889-97.

PMID:6940410
Abstract
摘要

相似文献

1
[Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].抗凝血酶III的研究。II. 抗凝血酶III（ATIII）在控制弥散性血管内凝血（DIC）中的作用。（ATIII浓缩物在实验性DIC和临床DIC中的给药效果）（作者译）
Nihon Ketsueki Gakkai Zasshi. 1980 Oct;43(5):889-97.
2
Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.抗凝血酶III浓缩剂用于治疗儿童弥散性血管内凝血。
Am J Pediatr Hematol Oncol. 1985 Spring;7(1):3-8.
3
[An experimental study on the protective effect of ATIII against acute disseminated intravascular coagulation].
Nihon Ketsueki Gakkai Zasshi. 1986 Aug;49(5):1081-90.
4
Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.重组人可溶性血栓调节蛋白（rhs-TM）对血浆抗凝血酶III水平降低的大鼠弥散性血管内凝血模型的影响。
Thromb Haemost. 1994 Apr;71(4):452-5.
5
[Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].[肝素和/或抗凝血酶III在兔内毒素诱导的弥散性血管内凝血模型中的作用]
Sangre (Barc). 1992 Feb;37(1):5-10.
6
[Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].[关于肝素和抗凝血酶III在弥散性血管内凝血治疗应用中的当前观点]
Pol Tyg Lek. 1989;44(40-42):896-8.
7
Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.新开发的危重病弥散性血管内凝血诊断标准对接受抗凝血酶 III 治疗的患者的影响。
Clin Appl Thromb Hemost. 2009 Oct;15(5):561-6. doi: 10.1177/1076029608323497. Epub 2008 Oct 7.
8
Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.在有或没有弥散性血管内凝血的脓毒症患者管理中停止给予抗凝血酶III的影响。
Blood Coagul Fibrinolysis. 2014 Dec;25(8):795-800. doi: 10.1097/MBC.0000000000000115.
9
[Fundamental studies on the management of disseminated intravascular coagulation (DIC) with antithrombin III (AT-III) concentrate].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Apr;37(4):571-80.
10
[Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].休克时消耗性凝血病的预防。肝素作用与抗凝血酶III活性的关系（作者译）
Anaesthesist. 1980 Nov;29(11):623-6.